RCKT
NASDAQ · Biotechnology
Rocket Pharmaceuticals Inc
$3.37
-0.13 (-3.71%)
Analyst Consensus
Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
+400.6% upside
Low Target
$13.87
Average Target
$16.87
High Target
$23.44
Current Price
$3.37
Current
$3.37
$3.37
Target
$16.87
$16.87
$13.87
$16.87 avg
$23.44
Scenario Analysis
Bear Case
$13.87
311.6%
Low target
Base Case
$16.87
+400.6%
Avg target
Bull Case
$23.44
+595.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$5.45
-38.2% from high
52-Week Low
$2.53
+33.2% from low
Target vs 52W High
$16.87
+209.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.0% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -15.6% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |